Indication
Intranasal Administration
1 clinical trial
1 product
Clinical trial
Towards the Improvement of the Treatment of Acute Relapses in Multiple Sclerosis: A Randomized Double-blind, Non-inferiority Controlled Trial Comparing Intranasal Versus Intravenous MethylprednisoloneStatus: , Estimated PCD: 2024-11-27
Product
Nasal Methylprednisolone